Shopping Cart 0
Cart Subtotal
USD 0

Blood Purification Equipment Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4900

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6860

Details

The Blood Purification Equipment market is expected to witness robust growth due to the increase in the prevalence of chronic kidney patients. FDA-Regulated blood purification medical equipment follows precisely documented processes and their performance growing popularity for greater convenience and better clinical outcomes. Transplantation and dialysis are the preferred treatment approaches for End-Stage Renal Diseases which led to the trigger of the global blood purification Equipment Market. Blood purification devices may be effective at treating certain patients with COVID-19 by reducing various pathogens, cytokines, and other inflammatory mediators. The small active proteins in the bloodstream that control a cell's immune response are filtering the blood and returning the filtered blood to the patient.

B. Braun Avitum signed a co-marketing agreement with CytoSorbents Corporation, a critical care immunotherapy leader. The agreement was aimed to promote the use of CytoSorb with B. Braun's latest OMNI continuous blood purification platform and OMNIset Plus bloodline set (set version 3.0 or higher).

Based on Type, the Global Blood Purification Equipment Market is segmented into Dialysis, CRRT, Hemoperfusion, and Others. Basic improvements in the dialysis system, from the membrane and the tubing system to the dialysis monitor, have laid the basis for this development. The understanding of underlying purification equipment and their settings in terms of optimal therapy has also led to the reduction of side effects that used to occur and therefore improved the quality of life and reduced mortality. The dialysis segment held major share of the global blood purification equipment market in 2020.

In terms of application, the global blood purification equipment market has been divided into sepsis, COVID-19, infectious diseases, acute kidney injury, and others. The acute kidney injury segment is anticipated to lead the global blood purification equipment market during the forecast period.

Based on end user, the global blood purification equipment market has been categorized into hospitals & clinics, dialysis centers, and others. The clinics segment would display a significant growth rate during the forecast period. Clinics are integrated with cutting-edge medical devices & equipment. Using blood purification services, clinics can provide speedier patient recovery as these clinics follow international regulations. The people who are currently going through renal failures are generally inclined towards blood purification from clinics that would fuel the growth of the global market.

For a better understanding of the market penetration of the hardware as a service market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America constitutes a major market for the hardware as a service industry and generated revenue of USD XX million in 2020 owing to the presence of well-established players in the region, like increasing geriatric population. A major segment of the geriatric population suffers from one or other types of chronic renal diseases that would act as a driver for the growth of the market. Moreover, the growth of the regional market would be propelled by favourable government regulations regarding blood purification equipment.

Some of the major players operating in the market Cytosorbents Corporation, Baxter International, Inc., ExThera Medical Corporation, Aethlon Medical, Inc., Fresenius SE & Co. KGaA, Cerus Corporation, Jafron Biomedical Co., Ltd., Spectra Medical, Inc., B. Braun Melsungen AG.

The global Blood Purification Equipment market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The global Blood Purification Equipment market is expected to witness a boost as blood purification plays a crucial part in various kidney & blood-related diseases. Developments in filtration & dialysis methods along with adsorption methods have boosted the adoption of these machines in various critical treatments.
READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Blood Purification Equipment Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Blood Purification Equipment Market

2.1.1 Main Objective of the Global Blood Purification Equipment Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET REVENUE

7 MARKET INSIGHTS BY TYPE

7.1 Dialysis

7.2 CRRT

7.3 Hemoperfusion

8 MARKET INSIGHTS BY PRODUCT TYPE

8.1 Portable

8.2 Stationary

9 MARKET INSIGHTS BY APPLICATION

9.1 Sepsis

9.2 Covid 19

9.3 Infectious Disease

9.4 Acute Kidney Injury

10 MARKET INSIGHTS BY END USER

10.1 Hospitals & Clinics

10.2 Dialysis Centers

10.3 Others

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA BLOOD PURIFICATION EQUIPMENT MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE BLOOD PURIFICATION EQUIPMENT MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC BLOOD PURIFICATION EQUIPMENT MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD BLOOD PURIFICATION EQUIPMENT MARKET

12 BLOOD PURIFICATION EQUIPMENT MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14 14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 BLOOD PURIFICATION EQUIPMENT MARKET OPPORTUNITIES

17 BLOOD PURIFICATION EQUIPMENT MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Baxter International, Inc.

19.2 Cytosorbents Corporation

19.3 ExThera Medical Corporation

19.4 Aethlon Medical, Inc.

19.5 Fresenius SE & Co. KGaA

19.6 Cerus Corporation

19.7 Jafron Biomedical Co. Ltd.

19.8 Spectra Medical, Inc.

19.9 B. Braun Melsungen AG

19.10 Nikkiso Co, Ltd

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Cytosorbents Corporation, Baxter International, Inc., ExThera Medical Corporation, Aethlon Medical, Inc., Fresenius SE & Co. KGaA, Cerus Corporation, Jafron Biomedical Co., Ltd., Spectra Medical, Inc., B. Braun Melsungen AG

Company Profile

Company Profile Title

The Blood Purification Equipment market is expected to witness robust growth due to the increase in the prevalence of chronic kidney patients. FDA-Regulated blood purification medical equipment follows precisely documented processes and their performance growing popularity for greater convenience and better clinical outcomes. Transplantation and dialysis are the preferred treatment approaches for End-Stage Renal Diseases which led to the trigger of the global blood purification Equipment Market. Blood purification devices may be effective at treating certain patients with COVID-19 by reducing various pathogens, cytokines, and other inflammatory mediators. The small active proteins in the bloodstream that control a cell's immune response are filtering the blood and returning the filtered blood to the patient.

B. Braun Avitum signed a co-marketing agreement with CytoSorbents Corporation, a critical care immunotherapy leader. The agreement was aimed to promote the use of CytoSorb with B. Braun's latest OMNI continuous blood purification platform and OMNIset Plus bloodline set (set version 3.0 or higher).

Based on Type, the Global Blood Purification Equipment Market is segmented into Dialysis, CRRT, Hemoperfusion, and Others. Basic improvements in the dialysis system, from the membrane and the tubing system to the dialysis monitor, have laid the basis for this development. The understanding of underlying purification equipment and their settings in terms of optimal therapy has also led to the reduction of side effects that used to occur and therefore improved the quality of life and reduced mortality. The dialysis segment held major share of the global blood purification equipment market in 2020.

In terms of application, the global blood purification equipment market has been divided into sepsis, COVID-19, infectious diseases, acute kidney injury, and others. The acute kidney injury segment is anticipated to lead the global blood purification equipment market during the forecast period.

Based on end user, the global blood purification equipment market has been categorized into hospitals & clinics, dialysis centers, and others. The clinics segment would display a significant growth rate during the forecast period. Clinics are integrated with cutting-edge medical devices & equipment. Using blood purification services, clinics can provide speedier patient recovery as these clinics follow international regulations. The people who are currently going through renal failures are generally inclined towards blood purification from clinics that would fuel the growth of the global market.

For a better understanding of the market penetration of the hardware as a service market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America constitutes a major market for the hardware as a service industry and generated revenue of USD XX million in 2020 owing to the presence of well-established players in the region, like increasing geriatric population. A major segment of the geriatric population suffers from one or other types of chronic renal diseases that would act as a driver for the growth of the market. Moreover, the growth of the regional market would be propelled by favourable government regulations regarding blood purification equipment.

Some of the major players operating in the market Cytosorbents Corporation, Baxter International, Inc., ExThera Medical Corporation, Aethlon Medical, Inc., Fresenius SE & Co. KGaA, Cerus Corporation, Jafron Biomedical Co., Ltd., Spectra Medical, Inc., B. Braun Melsungen AG.

The global Blood Purification Equipment market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The global Blood Purification Equipment market is expected to witness a boost as blood purification plays a crucial part in various kidney & blood-related diseases. Developments in filtration & dialysis methods along with adsorption methods have boosted the adoption of these machines in various critical treatments.
READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Blood Purification Equipment Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Blood Purification Equipment Market

2.1.1 Main Objective of the Global Blood Purification Equipment Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET REVENUE

7 MARKET INSIGHTS BY TYPE

7.1 Dialysis

7.2 CRRT

7.3 Hemoperfusion

8 MARKET INSIGHTS BY PRODUCT TYPE

8.1 Portable

8.2 Stationary

9 MARKET INSIGHTS BY APPLICATION

9.1 Sepsis

9.2 Covid 19

9.3 Infectious Disease

9.4 Acute Kidney Injury

10 MARKET INSIGHTS BY END USER

10.1 Hospitals & Clinics

10.2 Dialysis Centers

10.3 Others

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA BLOOD PURIFICATION EQUIPMENT MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE BLOOD PURIFICATION EQUIPMENT MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC BLOOD PURIFICATION EQUIPMENT MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD BLOOD PURIFICATION EQUIPMENT MARKET

12 BLOOD PURIFICATION EQUIPMENT MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14 14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 BLOOD PURIFICATION EQUIPMENT MARKET OPPORTUNITIES

17 BLOOD PURIFICATION EQUIPMENT MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Baxter International, Inc.

19.2 Cytosorbents Corporation

19.3 ExThera Medical Corporation

19.4 Aethlon Medical, Inc.

19.5 Fresenius SE & Co. KGaA

19.6 Cerus Corporation

19.7 Jafron Biomedical Co. Ltd.

19.8 Spectra Medical, Inc.

19.9 B. Braun Melsungen AG

19.10 Nikkiso Co, Ltd

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Cytosorbents Corporation, Baxter International, Inc., ExThera Medical Corporation, Aethlon Medical, Inc., Fresenius SE & Co. KGaA, Cerus Corporation, Jafron Biomedical Co., Ltd., Spectra Medical, Inc., B. Braun Melsungen AG